374Water (SCWO) 10-Q 12 Aug 14 2014 Q2 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	6 Months Ended
	Jun. 30, 2014	Aug. 12, 2014
Document And Entity Information	'	'
Entity Registrant Name	'POWERVERDE, INC.	'
Entity Central Index Key	'0000933972	'
Document Type	'10-Q	'
Document Period End Date	30-Jun-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	30,750,106
Document Fiscal Period Focus	'Q2	'
Document Fiscal Year Focus	'2014	'

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Jun. 30, 2014	Dec. 31, 2013
Current Assets:	'	'
Cash and cash equivalents	$8,403	$48,306
Accounts receivable	125,975	49,844
Employee advances	19,292	19,292
Prepaid expenses	11,725	18,366
Total Current Assets	165,395	135,808
Property and Equipment	'	'
Property and equipment, net of accumulated depreciation of $46,392 and $38,616, respectively	61,249	55,434
Other Assets	'	'
Intellectual Property, net of accumulated amortization of $494,580 and $384,673, respectively	164,860	274,767
Total Assets	391,504	466,009
Current Liabilities	'	'
Accounts payable and accrued expenses	126,336	43,575
Payable to related parties	71,965	163,965
Notes payable to related parties	356,719	314,140
Total Liabilities	555,020	521,680
Stockholders' Deficiency	'	'
Common stock: 100,000,000 common shares authorized, par value $0.0001 per share, 30,750,106 common shares issued and outstanding at June 30, 2014 and 27,600,106 common shares issued and outstanding at December 31, 2013	3,882	3,567
Additional paid-in capital	11,405,850	11,098,665
Treasury stock, 8,550,000 shares at cost	-491,139	-491,139
Deficit accumulated in the development stage	-11,082,109	-10,666,764
Total Stockholders' Deficiency	-163,516	-55,671
Total Liabilities and Stockholders' Deficiency	$391,504	$466,009

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Jun. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Accumulated depreciation of property and equipment (in Dollars)	$46,392	$38,616
Accumulated amortization of intellectual property (in Dollars)	$494,580	$384,673
Common stock, shares authorized	100,000,000	100,000,000
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares issued	30,750,106	27,600,106
Common stock, shares outstanding	30,750,106	27,600,106
Treasury stock, shares	8,550,000	8,550,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Operations (USD $)	3 Months Ended		6 Months Ended		85 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Income Statement [Abstract]	'	'	'	'	'
Revenue, Net	$125,975	$109,416	$166,129	$180,903	$1,003,940
Cost of Goods Sold	'	'	'	'	136,925
Gross Profit	125,975	109,416	166,129	180,903	867,015
Operating Expenses	'	'	'	'	'
Research and development	111,115	77,405	262,596	313,562	4,051,141
General and administrative	101,887	189,827	255,322	642,504	4,750,011
Goodwill impairment	'	'	'	'	2,637,760
Total Operating Expenses	213,002	267,232	517,918	956,066	11,438,912
Loss from Operations	-87,027	-157,816	-351,789	-775,163	-10,571,897
Other Income (Expenses)	'	'	'	'	'
Interest income	'	'	'	'	2,401
Interest expense	-42,368	-22,021	-63,556	-41,759	-568,624
Other income (expenses)	'	4,000	'	44,750	56,011
Total Other Income (Expense)	-42,368	-18,021	-63,556	2,991	-510,212
Loss before Income Taxes	-129,395	-175,837	-415,345	-772,172	-11,082,109
Provision for Income Taxes	'	'	'	'	'
Net Loss	($129,395)	($175,837)	($415,345)	($772,172)	($11,082,109)
Net Loss per Share - Basic and Diluted	($0.00)	($0.01)	($0.01)	($0.03)	'
Weighted Average Common Shares Outstanding - Basic and Diluted	30,197,908	26,416,590	29,778,007	26,220,721	'

Consolidated_Statement_of_Chan

Consolidated Statement of Changes in Stockholders' Deficiency (USD $)	6 Months Ended					6 Months Ended
	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Jun. 30, 2014	Dec. 31, 2013	Jun. 30, 2014
		Common Stock	Additional Paid-In Capital	Treasury Stock [Member]	Treasury Stock [Member]	Accumulated Deficit during the Development Stage
Balance	($55,671)	$3,567	$11,098,665	($491,139)	($491,139)	($10,666,764)
Balance, Shares	'	27,600,106	'	'	'	'
Sale of common stock	'	315	'	'	'	'
Sale of common stock, shares	307,500	3,150,000	307,185	'	'	'
Common stock issued for services	'	'	'	'	'	'
Common Stock Issued for services, shares	'	'	'	'	'	'
Stock-based compensation	'	'	'	'	'	'
Warrants issued for services	'	'	'	'	'	'
Warrants issued in connection with Notes payable to related party	'	'	'	'	'	'
Common stock issued on conversion of debt	'	'	'	'	'	'
Cashless exercise of options	'	'	'	'	'	'
Net loss for the six months ended June 30, 2014	-415,345	'	'	'	'	-415,345
Balance	($163,516)	$3,882	$11,405,850	($491,139)	($491,139)	($11,082,109)
Balances, Shares	'	30,750,106	'	'	'	'

Consolidated_Statement_of_Chan1

Consolidated Statement of Changes in Stockholders' Deficiency (Parenthetical) (USD $)	6 Months Ended
	Jun. 30, 2014
Consolidated Statement Of Changes In Stockholders Equity Parenthetical	'
Sale of common stock price per share	$0.10
Stock issuance costs	$7,500

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Cash Flows (USD $)	6 Months Ended		85 Months Ended
	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2014
Cash Flows from Operating Activities	'	'	'
Net loss	($415,345)	($772,172)	($11,082,109)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation and amortization	117,683	113,424	540,972
Amortization of discount	42,579	21,061	483,565
Stock based compensation	'	121,237	1,302,767
Common stock issued for services	'	124,750	124,750
Goodwill impairment	'	'	2,637,760
Warrants issued for services	'	210,000	822,150
Warrants issued for settlement	'	'	262,700
Gain on re-measurement of derivative liability	'	-44,750	-40,000
Changes in operating assets and liabilities:	'	'	'
Accounts receivable and prepaid expenses	-69,490	12,892	-137,700
Employee advances	'	-19,292	-19,292
Accounts payable and accrued expenses	82,761	148,598	-104,196
Payable to related parties	92,000	1,734	60,812
Cash Used in Operating Activities	-333,812	-82,518	-5,147,821
Cash Flows From Investing Activities	'	'	'
Purchase of property and equipment	-13,591	-55,904	-107,641
Cash acquired in business acquisition	'	'	872
Cash Used in Investing Activities	-13,591	-55,904	-106,769
Cash Flows from Financing Activities	'	'	'
Proceeds from issuance of common stock	315,000	125,000	5,665,281
Proceeds from notes payable to related parties	'	75,000	700,000
Payment of line of credit	'	'	-50,000
Payment of note payable to related parties	'	'	-271,206
Purchase of treasury stock	'	'	-320,381
Payment of stock issuance costs	-7,500	'	-460,701
Cash Provided by Financing Activities	307,500	200,000	5,262,993
Net Increase (decrease) in Cash and Cash Equivalents	-39,903	61,578	8,403
Cash and Cash Equivalents at Beginning of Period	48,306	45,283	'
Cash and Cash Equivalents at End of Period	8,403	106,861	8,403
Supplemental Disclosure of Cash Flow Information	'	'	'
Cash paid during the period for interest	'	20,705	20,705
Cash paid during the period for income taxes	'	'	24,221
Supplemental Schedule of Non-Cash Financing Activities	'	'	'
Common stock issued for convertible debt	'	'	189,261
Common stock issued for services	'	11,458	124,750
Common stock issued for acquisition of Cornerstone Conservation Group, LLC	'	'	3,096,200
Warrants issued in connection with acquisition of Cornerstone Conservation Group, LLC	'	'	201,000
Purchase of treasury stock with long-term related party payable	'	'	242,758
Warrants issued in connection with debt	'	'	299,984
Issuance of warrants as part of notes payable to related party of which $88,000 ($16,500 in Q1 2013) was classified as additional paid in capital and $88,000 ($16,500 in Q1 2013) was classified as a derivative liability	'	33,000	176,000
Warrants issued in connection with derivative liability	'	'	48,000
Common stock issued in connection with debt forgiveness and services rendered	'	'	$250,000

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Parenthetical) (USD $)	3 Months Ended	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2014
Statement of Cash Flows [Abstract]	'	'
Fair value of the common stock warrants recorded as additional paid in capital	$16,500	$88,000
Fair value of the common stock warrants recorded as derivative liability	$16,500	$88,000

Note_1_Condensed_Consolidated_

Note 1 - Condensed Consolidated Financial Statements	6 Months Ended
	Jun. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Condensed Consolidated Financial Statements	'
	Note 1 – Condensed Consolidated Financial Statements
	The accompanying unaudited condensed consolidated financial statements prepared in accordance with instructions for Form 10-Q, include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report of PowerVerde, Inc. (“PowerVerde,” “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2013. The results of operations for the three and six months ended June 30, 2014, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of PowerVerde, Inc., formerly known as Vyrex Corporation (the “Company"), and PowerVerde Systems, Inc., formerly known as PowerVerde, Inc., its wholly-owned subsidiary. Intercompany balances and transactions have been eliminated in consolidation.

Note_2_Going_Concern

Note 2 - Going Concern	6 Months Ended
	Jun. 30, 2014
Going Concern Note [Abstract]	'
Going Concern	'
	Note 2 – Going Concern
	The accompanying condensed consolidated financial statements have been prepared assuming the Company will continue as a going concern. The Company has had recurring operating losses and negative cash flows from operations. Those factors, as well as uncertainty in securing additional funds for continued operations, create an uncertainty about the Company’s ability to continue as a going concern. The condensed consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note_3_Summary_of_Significant_

Note 3 - Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Summary of Significant Accounting Policies	'
	Note 3 – Summary of Significant Accounting Policies
	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of PowerVerde, Inc. and its wholly-owned subsidiary, PowerVerde Systems, Inc. All significant intercompany balances and transactions have been eliminated in consolidation.
	Development Stage Company
	The Company is a development stage company as defined in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 915, “Development Stage Entities”. The Company is devoting substantially all of its present efforts to establish a new business and none of its planned principal operations have commenced. All losses accumulated since inception have been considered as part of the Company’s development stage activities.
	Cash Equivalents
	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
	Accounts Receivable
	Accounts receivable consist of balances due from sales and royalties. The Company monitors accounts receivable and provides allowances when considered necessary. At June 30, 2014, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.
	Employee Advances
	The employee advances represent the payroll taxes due on the issuance of common stock as compensation.
	Revenue Recognition
	Sales revenues and associated cost of sales are recognized when title of the goods sold pass to the buyer, when shipped and when accounts receivable are determined to be reasonably collectable. Certain sales agreements also require installation and training by PowerVerde once goods are received and accepted by the customer. The Company does not consider these agreements multiple elements arrangements as defined by ASC 605-25 “Revenue Recognition”, as the Company does not offer installation or training as services separate from the sale of its products at this time. Therefore, a “best estimate of selling price” or individual pricing in accordance with ASC 605-25 is undeterminable. The Company defers all revenues and costs of sales until the agreement is 100% complete.
	Licensing and royalty revenue from royalty agreements is recognized in accordance with the terms of the specific agreement.
	Property and Equipment
	Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.
	Impairment of Long-Lived Assets
	Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses have been recognized during the six months ended June 30, 2014 or 2013.
	Stock-based Compensation
	The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.
	Common Stock Purchase Warrants
	The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
	Accounting for Uncertainty in Income Taxes
	The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
	Research and Development Costs
	The Company’s research and development costs are expensed in the period in which they are incurred.
	Earnings (Loss) Per Share
	Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Basic earnings (loss) per share is computed by dividing net income (loss), after deducting preferred stock dividends accumulated during the period, by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 5,586,000 shares and options for 2,750,000 shares were excluded from weighted average common shares outstanding on a diluted basis.
	Financial instruments
	The Company carries cash and cash equivalents, accounts receivable, accounts payable and accrued expenses at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature. The Company also carries notes payable to related parties at historical cost less discounts from warrants issued as loan financing costs.
	Fair value of financial assets and liabilities
	The Company measures the fair value of financial assets and liabilities in accordance with GAAP which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
	GAAP defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. GAAP describes three levels of inputs that may be used to measure fair value:
	Level 1 – quoted prices in active markets for identical assets or liabilities
	Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable
	Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
	The Company generally does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has entered into certain other financial instruments and contracts, such as debt financing arrangements and freestanding warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. These instruments are required to be carried as derivative liabilities, at fair value.
	The Company uses the Black-Scholes valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to measure the fair value of these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective inputs that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the Company’s trading market price and the trading market price of various peer companies, which have historically had high volatility. Since derivative financial instruments are initially and subsequently carried at fair value, the Company’s income will reflect the volatility in these estimate and assumption changes.
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Note_4_Recent_Accounting_Prono

Note 4 - Recent Accounting Pronouncements	6 Months Ended
	Jun. 30, 2014
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]	'
Recent Accounting Pronouncements	'
	Note 4 – Recent Accounting Pronouncements
	In July 2013, the FASB issued guidance on the financial statement presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carry forward exists. This guidance requires the unrecognized tax benefit to be presented in the financial statements as a reduction to a deferred tax asset. When a deferred tax asset is not available, or the asset is not intended to be used for this purpose, an entity should present the unrecognized tax benefit in the financial statements as a liability. The guidance became effective for us at the beginning of our second quarter of fiscal 2014. The adoption of this guidance did not have a material impact on our consolidated financial statements.
	In January 2013, the FASB issued guidance clarifying the scope of disclosure requirements for offsetting assets and liabilities. The amended guidance limits the scope of balance sheet offsetting disclosures to derivatives, repurchase agreements, and securities lending transactions to the extent that they are offset in the financial statements of subject to an enforceable master netting arrangement or similar agreement. The guidance became effective for us at the beginning of our first quarter of fiscal 2014. The adoption of this guidance did not have a material impact on our consolidated financial statements.
	On June 10, 2014, the FASB issued Accounting Standards Update No. 2014-10 (ASU 2014-10), which eliminates development stage reporting requirements under ASC 915, as well as amends provisions of existing variable interest entity guidance under ASC 810. Additionally, the ASU indicates that the lack of commencement of principal operations represents a risk and uncertainty and, accordingly, is subject to the disclosure requirements of ASC 275.  As a result of the changes, existing development stage entity presentation and disclosure requirements are eliminated.  Nonpublic entities are no longer required to apply the presentation and disclosure provisions of ASC 915 during annual periods beginning after December 15, 2014, and the revisions to the consolidation standards are effective for annual periods beginning after December 15, 2016. Early adoption is permitted.
	In May 2014, the FASB issued Accounting Standards Update No. 2014-09, Revenue from Contracts with Customers (ASU 2014-09), which supersedes nearly all existing revenue recognition guidance under U.S. GAAP. The core principle of ASU 2014-09 is to recognize revenues when promised goods or services are transferred to customers in an amount that reflects the consideration to which an entity expects to be entitled for those goods or services. ASU 2014-09 defines a five step process to achieve this core principle and, in doing so, more judgment and estimates may be required within the revenue recognition process than are required under existing U.S. GAAP. The standard is effective for annual periods beginning after December 15, 2016, and interim periods therein, using either of the following transition methods: (i) a full retrospective approach reflecting the application of the standard in each prior reporting period with the option to elect certain practical expedients, or (ii) a retrospective approach with the cumulative effect of initially adopting ASU 2014-09 recognized at the date of adoption (which includes additional footnote disclosures). We are currently evaluating the impact of our pending adoption of ASU 2014-09 on our consolidated financial statements and have not yet determined the method by which we will adopt the standard in 2017.

Note_5_Intellectual_Property

Note 5 - Intellectual Property	6 Months Ended
	Jun. 30, 2014
Business Combinations [Abstract]	'
Intellectual Property	'
	Note 5 – Intellectual Property
	Intellectual property consists of technology acquired from the purchase of 100% of the membership interests of Cornerstone Conservation Group LLC (“Cornerstone”).
	For each of the six months ended June 30, 2014 and 2013, amortization expense was $109,907 and accumulated amortization of the intangible asset- intellectual property was $494,580 at June 30, 2014.
	Future amortization of the intangible asset – intellectual property was as follows as of June 30, 2014:
	Year ending December 31:
	2014 (after June 30, 2014)	$	109,907
	2015		54,953
	Total	$	164,860

Note_6_Stockholders_Equity

Note 6 - Stockholders' Equity	6 Months Ended
	Jun. 30, 2014
Stockholders' Equity Note [Abstract]	'
Stockholders' Equity	'
	Note 6 – Stockholders’ Equity
	Warrants
	The Company issued warrants on June 3, 2011 to various persons, including affiliates of the Company, for services provided to the Company. These warrants covered the purchase of 1,855,000 unregistered shares of the Company’s stock at an exercise price of $1.05 per share with a five-year term. These share-based payments have been accounted for in accordance with ASC 815-40 using the Black Scholes pricing model to determine the fair value of each warrant. As of June 30, 2014, all of these warrants were outstanding.
	On February 3, 2012, The Company issued warrants to purchase 500,000 unregistered shares of the Company’s common stock at an exercise price of $1.00 per share with a five-year term for settlement of certain disputed amounts. These share-based payments have been accounted for in accordance with ASC 815-40 using the Black-Scholes pricing model to determine the fair value of each warrant. As of June 30, 2014, all of these warrants were outstanding.
	In connection with the acquisition of Cornerstone (See Note 5), on March 30, 2012, the Company issued warrants to purchase 300,000 unregistered shares of common stock at exercise prices ranging from $2.00 to $4.00 per share. These warrants expire at various dates through December 2017. As of June 30, 2014, all of these warrants were outstanding.
	During the second quarter of 2012, the Company issued warrants to purchase 335,000 unregistered shares of the Company’s common stock at an exercise price of $3.00 per share in association with stock subscription agreements. These warrants expire on various dates through 2015. As of June 30, 2014, all of these warrants were outstanding.
	During the third quarter of 2012, the Company issued warrants to purchase 71,000 unregistered shares of the Company’s common stock at an exercise price of $3.00 per share in association with stock subscription agreements. These warrants expire July 30, 2015. As of June 30, 2014, all of these warrants were outstanding.
	During the fourth quarter of 2012, the Company issued warrants to purchase 225,000 unregistered shares of the Company’s common stock at an exercise price of $1.00 per share in association with stock subscription agreements. These warrants expire October 31, 2015. As of June 30, 2014, all of these warrants were outstanding.
	In December 2012, the Company issued warrants to purchase 325,000 unregistered shares of the Company’s common stock at an exercise price of $.41 per share in association with the Secured Promissory Note (See Note 8). These warrants expire December 31, 2015. As of June 30, 2014, all of these warrants were outstanding.
	During January 2013, the Company issued three-year warrants to purchase 75,000 unregistered shares of the Company’s common stock at an exercise price of $.41 per share in association with the Secured Promissory Note (See Note 8). These warrants expire December 31, 2015. As of June 30, 2014, all of these warrants were outstanding.
	During March 2013, the Company issued its Chief Executive Officer and Chief Financial Officer five –year warrants to purchase common stock at an exercise price of $.30 per share (market price on date of grant) in the amounts of 1,000,000 and 500,000 shares, respectively. The Company recognized $210,000 in compensation expense. As of June 30, 2014, all of these warrants were outstanding.
	On December 1, 2013, the Company issued additional three-year warrants to purchase 400,000 unregistered shares of the Company’s common stock at an exercise price equal to $0.21 per share (the average closing price of the common stock during the 10 trading days prior to December 1, 2013). This was in association with the Secured Promissory Note (See Note 8). These warrants expire December 31, 2016. As of June 30, 2014, all of these warrants were outstanding.
	Expenses related to warrants issued in conjunction with settlement of certain disputes are included in the condensed consolidated statement of operations.
	A summary of warrants issued, exercised and expired during the six months ended June 30, 2014 is as follows:
		Shares			Weighted Average Exercise Price			Aggregate Intrinsic Value
	Balance at December 31, 2013		7,586,000		$	0.92		$	45,000
	Issued		—			—			—
	Expired		(2,000,000	)		(.75	)		—
	Balance at June 30, 2014		5,586,000		$	0.99		$	45,000
	Common Stock Issued for Services
	In the first quarter of 2013, the Company issued 125,000 common shares to a third party for six months consulting services and 200,000 common shares were issued to an employee as part of his compensation package. Expenses of $113,292 and $11,458, were recognized in the first and second quarter 2013, respectively, and included in the general and administrative expenses on the condensed consolidated statement of operations.
	Private Placement of Common Stock
	In the second quarter of 2013, the Company raised gross proceeds of $125,000 through private placement of 500,000 unregistered shares of common stock to accredited investors at $.25 per share.
	In the third quarter of 2013, the Company raised gross proceeds of $150,000 through private placement of 600,000 unregistered shares of common stock to accredited investors at $.25 per share.
	In the fourth quarter of 2013, the Company raised gross proceeds of $25,000 through private placement of 100,000 unregistered shares of common stock to accredited investors at $.25 per share.
	In the first quarter of 2014, the Company raised gross proceeds of $240,000 through private placement of 2,400,000 unregistered shares of common stock to accredited investors at $.10 per share.
	In the second quarter of 2014, the Company raised gross proceeds of $75,000 through private placement of 750,000 unregistered shares of common stock to accredited investors at $.10 per share.
	Treasury Shares
	In May 2012, the Company purchased 450,000 shares of its common stock from its Co-Founder and Director Fred Barker at a price of $0.20 per share. Of the $90,000 purchase price, $10,000 was paid at closing and the balance is payable $10,000 per month through January 2013. As of June 30, 2014, the Company has paid the debt in full and has no further obligations.
	On October 16, 2012, 3,000,000 shares of the Company’s stock were surrendered to Treasury by Company Co-Founder and former President and Director George Konrad, in exchange for $530,000, $100,000 of which is due in six equal monthly installments, beginning on November 16, 2012. The Company only made one of the required payments during 2013 and the payment schedule was renegotiated in the first quarter of 2014. The payable had a balance of $100,000, including accrued interest, as of December 31, 2013 and is included in the “Payable to related parties” in the accompanying consolidated condensed balance sheets. The $100,000 debt was paid in the first quarter of 2014.

Note_7_Stock_Options

Note 7 - Stock Options	6 Months Ended
	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Stock Options	'
	Note 7 – Stock Options
	Stock option activity for the six months ended June 30, 2014, is summarized as follows:
		Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
	Options outstanding at December 31, 2013		2,750,000	$	0.78		7
	Granted		—		—		—
	Expired/forfeited		—		—		—
	Options outstanding at June 30, 2014		2,750,000	$	0.78		6
	Total stock option compensation for the six months ended June 30, 2014 was $0 and $121,237 for the same period in 2013. There is no unrecognized compensation expense associated with the options.

Note_8_Notes_Payable_to_Relate

Note 8 - Notes Payable to Related Parties	6 Months Ended
	Jun. 30, 2014
Notes Payable [Abstract]	'
Notes Payable to Related Parties	'
	Note 8 - Notes Payable to Related Parties
	In the fourth quarter of 2012, in an effort to raise capital, the Company entered into various Secured Promissory Note agreements with accredited investors, who are also existing stockholders of the Company. As of December 31, 2013, $400,000 was raised, of which $325,000 was raised in 2012 and $75,000 in the first quarter of 2013. Upon closing, the Company issued to the investors three-year warrants for the purchase of 400,000 shares (in the aggregate) of the Company’s common stock at a price of $.41 per share and a commitment to issue additional warrants on December 1, 2013. On December 1, 2013, the Company issued additional three-year warrants for 400,000 shares to the investors at an exercise price equal to $.21 per share (the average price of the common stock during the 10 trading days prior to December 1, 2013).
	The promissory notes bear interest at the rate of 10% per annum based on a 365-day year. Accrued interest will be paid semi-annually on June 30, 2013, December 31, 2013, June 30, 2014, and December 31, 2014. The entire principal balance of the Note, together with all unpaid interest accrued thereon, shall be due and payable on December 31, 2014. In the event the Company defaults on interest and/or principal payments, the Company will use all accounts receivable obtained now or hereafter existing, pursuant to the License Agreement from VDF FutureCeuticals Inc. (the “Licensee”), as collateral. Accrued interest of $19,836 through June 30, 2014 was paid to the investors in the second quarter of 2014.
	The Company analyzed the terms of the warrants based on the provisions of ASC 480, “Distinguishing Liabilities from Equity,” and determined that the warrants issued in conjunction with the closing of the notes payable qualified for equity accounting. The warrants that were issued on December 1, 2013 were classified as derivative liabilities until issuance on December 1, 2013. On December 1, 2013 the Company determined that the warrants qualified as equity accounting and as such the Company reclassified the fair value of the derivative liability to equity at December 1, 2013.
	Under guidance in ASC 470, the Company allocated the $400,000 in proceeds proportionately between the Secured Promissory Note and the common stock warrants issued to the note holders based on their relative fair values. The relative fair value of the common stock warrants of $176,000, of which $88,000 ($16,500 in Q1 2013) was recorded as additional paid in capital and $88,000 ($16,500 in Q1 2013) was recorded as a derivative liability. The Secured Promissory Note was recorded at the principal amount of $400,000 less a discount of $176,000. This discount is being amortized to interest expense over the term of the Secured Promissory Note to related parties using the effective interest method. The fair value of the common stock warrants issued in conjunction with the Secured Promissory Notes was determined using the Black-Scholes pricing model. The Company determined the fair value of its common stock warrants to be $0.22 per warrant issued with an exercise price of $0.41 per warrant.
	Upon payment in full of the notes, a $25,000 fee was to be paid by the Company to its placement agent, Martinez-Ayme Securities, Inc. Subsequently, the agreed upon amount was reduced to $20,000. In the fourth quarter of 2013, Martinez-Ayme Securities transferred the receivable to Richard Davis. As of June 30, 2014, $16,000 has been paid on this liability. The balance of $4,000 is reflected as a note payable to related parties in the condensed consolidated balance sheets.
	On May 19, 2013, the Company entered into a Promissory Note with Edward Gomez, a Company shareholder, for $30,000. The promissory note bears interest at the rate of 10% per annum based on a 365-day year. The entire principal balance, along with the accrued interest was due on May 19, 2014.
	On May 5, 2014, the Company entered into a Note Extension Agreement with Mr. Gomez to extend the maturity date of the principal balance to May 19, 2015 and paid the accrued interest of $3,000 through May 19, 2014.

Note_9_Commitments_and_Conting

Note 9 - Commitments and Contingencies	6 Months Ended
	Jun. 30, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Note 9 - Commitments and Contingencies
	On September 29, 2011, the Company entered into a license agreement (the “License Agreement”) with Newton Investments BV. Pursuant to the License Agreement, Newton will, for a period of 10 years, hold the exclusive manufacturing and distribution rights for the Systems in the 27 countries which are currently members of the European Union, subject to Newton’s achieving minimum sales of at least 100 Systems per year beginning in the second year of the License Agreement, payment of a royalty equal to 20% of the gross sales price of each System sold, and other terms and conditions set forth in the License Agreement. Due to ongoing technical problems with the Company’s Systems, the Company deferred commencement of the minimum sales requirement until the problems are resolved. On July 30, 2014, Newton terminated the License Agreement.
	On October 25, 2012, the Company entered into a consulting agreement with Hank Leibowitz, the principal of Waste Heat Solutions, LLC, an expert with 40 years’ experience in the field of advanced energy systems. Pursuant to this consulting agreement, which is terminable by either party on 30 days’ notice, the Company pays Waste Heat Solutions, $5,000 per month through February 2013 and $7,500 per month thereafter. In connection with this consulting agreement, the Company issued to Waste Heat Solutions (i) a fully vested 10-year option to purchase 500,000 shares of common stock at $.56 per share and (ii) a 10-year option, vesting six months from the contract date, i.e., on April 25, 2013, to purchase an additional 500,000 shares at $.56 per share. The fair value of the fully vested option was approximately $182,000 and was recorded as general and administrative expenses in the consolidated statements of operations during 2012. The fair value of the option vesting six months from the contract date was approximately $182,000 of which approximately $91,000 was recorded as research and development expense in the condensed consolidated statements of operations for the first quarter 2013. The remaining $30,300 was recognized in the second quarter of 2013 and is included in research and development expense in the accompanying condensed consolidated statements of operations.
	This consulting agreement contains standard confidentiality provisions, as well as standard non-competition and non-soliciting provisions which survive for two years following termination of the consultancy.
	On November 2, 2012, Keith Johnson, the Company’s former Chief Technical Officer, filed suit against the Company’s operating subsidiary PowerVerde Systems, Inc., in Maricopa County, Arizona, Superior Court. The suit included claims for breach of his employment agreement, for back pay and related claims. Mr. Johnson, whose salary was $12,500 per month, sought back pay of $37,500, reimbursement of expenses totaling approximately $5,012 and other unspecified damages. The Company believes that Mr. Johnson voluntarily terminated his employment in accordance with the agreement and that he has been paid in full. In an abundance of caution, the Company also gave Mr. Johnson 30 days’ notice of termination without cause pursuant to the employment agreement, with this notice to be effective only if the Court determines that his employment was not previously terminated by him. Mr. Johnson ceased working for the Company in early September 2012. Based on the foregoing, the Company believed that it had substantial defenses to Mr. Johnson’s claims, which were denied in the Company’s answer.
	In May 2014, the case was settled pursuant to the Company’s agreement to pay Mr. Johnson $30,088, with $5,088 due upon execution of the settlement agreement plus an additional $25,000 payable in installments of $12,500 each in July and August 2014. The installments due in July and August are included in the Payable to Related Parties on the condensed consolidated financial statements.  As of the date of this filing, all of the settlement payments have been made, and this case is concluded.

Note_10_Related_Party_Transact

Note 10 - Related Party Transactions	6 Months Ended
	Jun. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Note 10 - Related Party Transactions
	See Note 6 for discussion of transactions with the Company’s Co-Founders, George Konrad and Fred Barker and, Note 8 for discussion of a transaction with the Company’s CEO Richard Davis.

Note_3_Summary_of_Significant_1

Note 3 - Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2014
Accounting Policies [Abstract]	'
Principles of Consolidation	'
	Principles of Consolidation
	The condensed consolidated financial statements include the accounts of PowerVerde, Inc. and its wholly-owned subsidiary, PowerVerde Systems, Inc. All significant intercompany balances and transactions have been eliminated in consolidation.
Development Stage Company	'
	Development Stage Company
	The Company is a development stage company as defined in the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 915, “Development Stage Entities”. The Company is devoting substantially all of its present efforts to establish a new business and none of its planned principal operations have commenced. All losses accumulated since inception have been considered as part of the Company’s development stage activities.
Cash Equivalents	'
	Cash Equivalents
	The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents.
Accounts Receivable	'
	Accounts Receivable
	Accounts receivable consist of balances due from sales and royalties. The Company monitors accounts receivable and provides allowances when considered necessary. At June 30, 2014, accounts receivable were considered to be fully collectible. Accordingly, no allowance for doubtful accounts was provided.
Employee Advances	'
	Employee Advances
	The employee advances represent the payroll taxes due on the issuance of common stock as compensation.
Revenue Recognition	'
	Revenue Recognition
	Sales revenues and associated cost of sales are recognized when title of the goods sold pass to the buyer, when shipped and when accounts receivable are determined to be reasonably collectable. Certain sales agreements also require installation and training by PowerVerde once goods are received and accepted by the customer. The Company does not consider these agreements multiple elements arrangements as defined by ASC 605-25 “Revenue Recognition”, as the Company does not offer installation or training as services separate from the sale of its products at this time. Therefore, a “best estimate of selling price” or individual pricing in accordance with ASC 605-25 is undeterminable. The Company defers all revenues and costs of sales until the agreement is 100% complete.
	Licensing and royalty revenue from royalty agreements is recognized in accordance with the terms of the specific agreement.
Property and Equipment	'
	Property and Equipment
	Property and equipment are stated at cost, less accumulated depreciation. Depreciation is computed using the straight-line method over the estimated useful lives of the related assets. Expenditures for major betterments and additions are capitalized, while replacement, maintenance and repairs, which do not extend the lives of the respective assets, are expensed as incurred.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	Impairment losses are recorded on long-lived assets (property, equipment and intellectual property) used in operations when impairment indicators are present and the undiscounted expected cash flows estimated to be generated by those assets are less than the carrying value of such assets. No impairment losses have been recognized during the six months ended June 30, 2014 or 2013.
Stock-based compensation	'
	Stock-based Compensation
	The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.
Common Stock Purchase Warrants	'
	Common Stock Purchase Warrants
	The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, “Derivatives and Hedging – Contracts in Entity’s Own Equity” (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement).
Accounting for Uncertainty in Income Taxes	'
	Accounting for Uncertainty in Income Taxes
	The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements, and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.
Research and Development Costs	'
	Research and Development Costs
	The Company’s research and development costs are expensed in the period in which they are incurred.
Earnings (Loss) Per Share	'
	Earnings (Loss) Per Share
	Earnings (loss) per share is computed in accordance with FASB ASC Topic 260, “Earnings per Share”. Basic earnings (loss) per share is computed by dividing net income (loss), after deducting preferred stock dividends accumulated during the period, by the weighted-average number of shares of common stock outstanding during each period. Diluted earnings per share is computed by dividing net income by the weighted-average number of shares of common stock, common stock equivalents and other potentially dilutive securities outstanding during the period. Certain common stock equivalents were not included in the earnings (loss) per share calculation as their effect would be anti-dilutive. Warrants exercisable for 5,586,000 shares and options for 2,750,000 shares were excluded from weighted average common shares outstanding on a diluted basis.
Financial instruments	'
	Financial instruments
	The Company carries cash and cash equivalents, accounts receivable, accounts payable and accrued expenses at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values due to their current nature. The Company also carries notes payable to related parties at historical cost less discounts from warrants issued as loan financing costs.
Fair value of financial assets and liabilities	'
	Fair value of financial assets and liabilities
	The Company measures the fair value of financial assets and liabilities in accordance with GAAP which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
	GAAP defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. GAAP also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. GAAP describes three levels of inputs that may be used to measure fair value:
	Level 1 – quoted prices in active markets for identical assets or liabilities
	Level 2 – quoted prices for similar assets and liabilities in active markets or inputs that are observable
	Level 3 – inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
	The Company generally does not use derivative financial instruments to hedge exposures to cash-flow, market or foreign-currency risks. However, the Company has entered into certain other financial instruments and contracts, such as debt financing arrangements and freestanding warrants with features that are either (i) not afforded equity classification, (ii) embody risks not clearly and closely related to host contracts, or (iii) may be net-cash settled by the counterparty. These instruments are required to be carried as derivative liabilities, at fair value.
	The Company uses the Black-Scholes valuation technique because it embodies all of the requisite assumptions (including trading volatility, estimated terms and risk free rates) necessary to measure the fair value of these instruments. Estimating fair values of derivative financial instruments requires the development of significant and subjective inputs that may, and are likely to, change over the duration of the instrument with related changes in internal and external market factors. In addition, option-based techniques are highly volatile and sensitive to changes in the Company’s trading market price and the trading market price of various peer companies, which have historically had high volatility. Since derivative financial instruments are initially and subsequently carried at fair value, the Company’s income will reflect the volatility in these estimate and assumption changes.
Use of Estimates	'
	Use of Estimates
	The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.

Note_5_Intellectual_Property_T

Note 5 - Intellectual Property (Tables)	6 Months Ended
	Jun. 30, 2014
Note 5 - Intellectual Property Tables	'
Intellectual Property	'
	Future amortization of the intangible asset – intellectual property was as follows as of June 30, 2014:
	Year ending December 31:
	2014 (after June 30, 2014)	$	109,907
	2015		54,953
	Total	$	164,860

Note_6_Stockholders_Equity_Tab

Note 6 - Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2014
Stockholders' Equity Note [Abstract]	'
Schedule of summary of warrants issued, exercised and expired	'
	A summary of warrants issued, exercised and expired during the six months ended June 30, 2014 is as follows:
		Shares			Weighted Average Exercise Price			Aggregate Intrinsic Value
	Balance at December 31, 2013		7,586,000		$	0.92		$	45,000
	Issued		—			—			—
	Expired		(2,000,000	)		(.75	)		—
	Balance at June 30, 2014		5,586,000		$	0.99		$	45,000

Note_7_Stock_Options_Tables

Note 7 - Stock Options (Tables)	6 Months Ended
	Jun. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Schedule of stock option activity	'
	Stock option activity for the six months ended June 30, 2014, is summarized as follows:
		Shares		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (Years)
	Options outstanding at December 31, 2013		2,750,000	$	0.78		7
	Granted		—		—		—
	Expired/forfeited		—		—		—
	Options outstanding at June 30, 2014		2,750,000	$	0.78		6

Note_3_Summary_of_Significant_2

Note 3 - Summary of Significant Accounting Policies (Details 1)	6 Months Ended
	Jun. 30, 2013
Warrant [Member]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'
Number of warrants and options excluded from weighted average common shares outstanding	5,586,000
Stock Options [Member]	'
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]	'
Number of warrants and options excluded from weighted average common shares outstanding	2,750,000

Note_5_Intellectual_Property_D

Note 5 - Intellectual Property (Detail) - (Table 1) Future amortization of the intangible asset (USD $)	Jun. 30, 2014
Year ending December 31:	'
2014 (after June 30, 2014)	$109,907
2015	54,953
Total	$164,860

Note_5_Intellectual_Property_D1

Note 5 - Intellectual Property (Detail) (USD $)	3 Months Ended	6 Months Ended
	Mar. 31, 2013	Jun. 30, 2014	Dec. 31, 2013
Amortization expense	$109,907	$109,907	'
A.ccumulated amortization of the intangible asset- intellectual property	'	$494,580	$384,673
Cornerstone	'	'	'
Percentage of membership interests purchased	'	100.00%	'

Note_6_Stockholders_Equity_Det

Note 6- Stockholders' Equity (Detail) - (Table 1) Warrant Activity, Current Period (USD $)	6 Months Ended
	Jun. 30, 2014
Stockholders' Equity Note [Abstract]	'
Balance at December 31, 2013	7,586,000
Balance at December 31, 2013	$0.92
Balance at December 31, 2013	$45,000
Issued	'
Expired	-2,000,000
Expired	'
Expired	'
Balance at March 31, 2014	5,586,000
Balance at March 31, 2014	$0.99
Balance at March 31, 2014	$45,000

Note_6_Stockholders_Equity_Iss

Note 6 - Stockholders' Equity (Issue of Warrants to purchase shares of the Company's common stock) (Details) (USD $)

1 Months Ended

3 Months Ended

1 Months Ended

Dec. 31, 2013

Mar. 31, 2013

Jan. 31, 2013

Dec. 31, 2012

Mar. 31, 2012

Feb. 29, 2012

Jun. 30, 2011

Dec. 31, 2012

Sep. 30, 2012

Jun. 30, 2012

Mar. 31, 2012

Jun. 30, 2012

Maximum [Member]

Minimum [Member]

Company issued warrants to purchase unregistered shares of the Company's common stock

400,000

'

75,000

325,000

300,000

500,000

1,855,000

225,000

71,000

335,000

'

'

Exercise price per share in association with stock subscription agreements

$0.21

'

$0.41

$0.41

'

$1

$1.05

$1

$3

$3

$4

$2

Warrants term

'

'

'

'

'

'5 years

'5 years

'

'

'

'

'

Warrants expiration date

31-Dec-16

'

31-Dec-15

31-Dec-15

31-Dec-17

'

'

31-Oct-15

30-Jul-15

31-Dec-15

'

'

Company issued its Chief Executive Officer five year warrants to purchase common stock

'

1,000,000

'

'

'

'

'

'

'

'

'

'

Company issued its Chief Financial Officer five year warrants to purchase common stock

'

500,000

'

'

'

'

'

'

'

'

'

'

Company recognized an amount in compensation expense

'

$210,000

'

'

'

'

'

'

'

'

'

'

Exercise price per share in association with stock issued to Chief Executive Officer and Chief Financial Officer

'

$0.30

'

'

'

'

'

'

'

'

'

'

Note_6_Stockholders_Equity_Com

Note 6 - Stockholders' Equity (Common Stock Issued for Services) (Details) (USD $)	3 Months Ended
	Jun. 30, 2013	Mar. 31, 2013
Note 6 - Stockholders Equity Common Stock Issued For Services Details	'	'
Company issued common shares to a third party for six months consulting services	'	125,000
Common shares issued to an employee as part of his compensation package	'	200,000
The expense for the period included in the general and administrative expenses	$11,458	$113,292

Note_6_Stockholders_Equity_Pri

Note 6 - Stockholders' Equity (Private Placement of Common Stock) (Details) (USD $)	3 Months Ended
	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013
Note 6 - Stockholders Equity Private Placement Of Common Stock Details	'	'	'	'	'
Company raised gross proceeds through the private placement of unregistered shares of common stock to accredited investors	$75,000	$240,000	$25,000	$150,000	$125,000
Issue of unregistered shares of common stock to accredited investors	750,000	2,400,000	100,000	600,000	500,000
Price per share of common stock issuedto accredited investors	$0.10	$0.10	$0.25	$0.25	$0.25

Note_6_Stockholders_Equity_Tre

Note 6 - Stockholders' Equity (Treasury Shares transactions) (Details) (USD $)	3 Months Ended
	Mar. 31, 2014	Oct. 16, 2012	31-May-12	Dec. 31, 2011
Note 6 - Stockholders Equity Treasury Shares Transactions Details	'	'	'	'
Company purchased shares of common stock from Fred Barker	'	'	450,000	'
Purchase price of shares of common stock purchased from Fred Barker	'	'	$90,000	'
Purchase price per share of common stock purchased from Fred Barker	'	'	$0.20	'
Amount payable as equal monthly installments	'	100,000	10,000	'
The balance of the note payable was settled with the surrender of an additional shares of the Company's stock by George Konrad	'	3,000,000	'	'
Value of note exchanged in Treasury	'	530,000	'	'
Balance of payable included in the "Payable to related parties"	'	'	'	100,000
Repayment of debt	$100,000	'	'	'

Note_7_Stock_Options_Detail_Ta

Note 7 - Stock Options (Detail) - (Table 1) Stock Option Activity, Current Period (USD $)	6 Months Ended	12 Months Ended
	Jun. 30, 2014	Dec. 31, 2013
Shares	'	'
Options outstanding at December 31, 2013	2,750,000	'
Granted	'	'
Expired/forfeited	'	'
Options outstanding at March 31, 2014	2,750,000	2,750,000
Weighted Average Exercise Price	'	'
Balance at December 31, 2013	$0.92	'
Granted	'	'
Expired/forfeited	'	'
Balance at March 31, 2014	$0.99	$0.92
Weighted Average Remaining Contractual Life (Years)	'	'
Options outstanding	'6 years	'7 years

Note_7_Stock_Options_Detail

Note 7 - Stock Options (Detail) (USD $)	6 Months Ended
	Jun. 30, 2014	Jun. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'	'
Share-based Compensation	$0	$121,237

Note_8_Notes_Payable_to_Relate1

Note 8 - Notes Payable to Related Parties (Detail) (USD $)	1 Months Ended	3 Months Ended		12 Months Ended
	Dec. 31, 2013	Mar. 31, 2014	Mar. 31, 2013	Dec. 31, 2013	Jun. 30, 2014	19-May-14
Notes Payable [Abstract]	'	'	'	'	'	'
Proceeds from notes payable to related parties	'	'	$75,000	'	'	'
Proceeds from notes payable to related parties in 2012	'	325,000	'	'	'	'
Additional warrants issuable for purchase of common stock.	'	'	'	400,000	'	'
Number of trading days used for calculation of exercise price of additional warrant.	'	'10 years	'	'	'	'
Interest rate of promissory note	10.00%	'	'	'	'	'
Fair value of the common stock warrants recorded as additional paid in capital	'	'	16,500	'	'	'
Fair value of the common stock warrants recorded as derivative liability	'	'	16,500	'	'	'
Principal amount of secured promissory note	400,000	'	'	'	'	'
Discount on issue of secured promissory note	'	'	'	176,000	'	'
Fair value of common stock per share (in dollars per share)	$0.41	'	'	'	'	'
Fair value of the common stock warrants recorded as additional paid in capital till date	'	'	'	88,000	'	'
Fair value of the common stock warrants recorded as derivative liability till date	'	'	'	88,000	'	'
Fair value of common stock warrants issued (in dollars per share)	$0.21	$0.22	'	'	'	'
Accrued interest	'	'	'	'	$19,836	$3,000

Note_8_Notes_Payable_to_Relate2

Note 8 - Notes Payable to Related Parties (Detail 1) (USD $)	3 Months Ended
	Mar. 31, 2014	Jun. 30, 2014	19-May-14	19-May-13
Notes Payable [Abstract]	'	'	'	'
Fees payable to placement agent	$25,000	'	'	'
Accrued fees payable	20,000	'	'	'
Amount paid on Liability	4,000	'	'	'
Balance Amount Reflected In Notes Payable To Related Parties	16,000	'	'	'
Promissory Note with Edward Gomez	'	'	'	30,000
Promissory note bears interest rate	'	'	'	10.00%
Promissory note maturity date	19-May-14	'	'	'
Accrued interest	'	$19,836	$3,000	'

Note_9_Commitments_and_Conting1

Note 9 - Commitments and Contingencies (Detail) (USD $)	1 Months Ended		1 Months Ended
	Oct. 31, 2012	Oct. 25, 2012	31-May-14	Nov. 30, 2012
			Chief Technical Officer [Member]	Chief Technical Officer [Member]
Agreement terminable by either party notice period of days	'30 days	'	'	'
Company pays waste heat solutions per month through Feb. 2013	'	$5,000	'	'
Company pays waste heat solutions per month thereafter Feb. 2013	'	7,500	'	'
Fully vested 10-year option issued to purchase shares of common stock at $.56 per share	'	500,000	'	'
Right to Purchase of additional shares for options vesting six months from the date of contract	'	500,000	'	'
Fair value of the options fully vested recorded as Research and development cost	'	182,000	'	'
Price per share of the 10 year options	'	$0.56	'	'
Fair value of option vesting was recorded during the fourth quarter of 2012	'	182,000	'	'
Amount recorded during the first quarter of 2013	'	91,000	'	'
Amount recorded in the second quarter of 2013	'	30,300	'	'
Officers salary	'	'	'	12,500
Sought back pay to officers	'	'	'	37,500
Expenses reimbursement	'	'	'	5,012
Settlement, Amount	'	'	30,088	'
Due amount on settlement	'	'	5,088	'
Additional amount payble on settlement	'	'	25,000	'
Monthly Installment	'	'	$12,500	'